209 related articles for article (PubMed ID: 6085391)
21. Free intracellular calcium in essential hypertension. Effects of nifedipine and captopril.
Lenz T; Haller H; Lüdersdorf M; Kribben A; Thiede M; Distler A; Philipp T
J Hypertens Suppl; 1985 Dec; 3(3):S13-5. PubMed ID: 2856689
[TBL] [Abstract][Full Text] [Related]
22. Adrenoceptors, calcium, and vasoconstriction in normal and hypertensive humans.
Bühler FR; Bolli P; Erne P; Kiowski W; Müller FB; Hulthén UL; Ji BH
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S130-6. PubMed ID: 2414575
[TBL] [Abstract][Full Text] [Related]
23. [Calcium antagonists: a potent vasodilatory principle and alternative basic antihypertensive therapy].
Bolli P; Erne P; Bühler FR
Schweiz Med Wochenschr; 1983 Nov; 113(46):1733-5. PubMed ID: 6658418
[TBL] [Abstract][Full Text] [Related]
24. [Endothelin-induced vasoconstriction in man: variable modification caused by endothelium-derived relaxing factor, Sodium nitroprusside and calcium antagonists].
Kiowski W; Linder L; Lüscher TF; Bühler FR
Schweiz Med Wochenschr; 1992 Apr; 122(15):559-62. PubMed ID: 1566022
[TBL] [Abstract][Full Text] [Related]
25. Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
Knorr A; Stoepel K
Arzneimittelforschung; 1981; 31(12):2062-4. PubMed ID: 7199298
[TBL] [Abstract][Full Text] [Related]
26. Recognizing and treating two types of long-term vasoconstriction in hypertension.
Laragh JH; Resnick LM
Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
[TBL] [Abstract][Full Text] [Related]
27. Calcium antagonists, firstline partners for betablockers in hypertension.
Bühler FR
Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
[TBL] [Abstract][Full Text] [Related]
28. Calcium entry blockade and alpha-adrenergic responsiveness in vivo.
Pedrinelli R; Tarazi RC
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S199-205. PubMed ID: 2414588
[TBL] [Abstract][Full Text] [Related]
29. Effect of nifedipine on blood pressure and on intracellular calcium in arterial hypertension.
Zidek W; Losse H; Vetter H
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S303-5. PubMed ID: 6184558
[TBL] [Abstract][Full Text] [Related]
30. Hypercholesterolemia modulates the effects of nitrendipine on blood pressure and platelet function in essential hypertension.
Mazeaud MM; Sang KH; Astarie C; Levenson J; Simon A; Devynck MA
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S46-51. PubMed ID: 1725003
[TBL] [Abstract][Full Text] [Related]
31. Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension.
Sudano I; Virdis A; Taddei S; Spieker L; Corti R; Noll G; Salvetti A; Luscher TF
Hypertension; 2007 Feb; 49(2):285-90. PubMed ID: 17178974
[TBL] [Abstract][Full Text] [Related]
32. Nitrendipine in hypertension that is difficult to control.
Höffler D; Stoepel K
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1060-2. PubMed ID: 6085367
[TBL] [Abstract][Full Text] [Related]
33. Alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm: differences between normotensive and hypertensive subjects.
Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
J Hypertens Suppl; 1985 Dec; 3(3):S89-91. PubMed ID: 2908822
[TBL] [Abstract][Full Text] [Related]
34. Time course of regression of vascular structural changes and its relation to cytosolic free calcium in hypertensives after nilvadipine treatment.
Ueno H; Takata M; Oh-hashi S; Tomoda F; Yasumoto K; Inoue H
J Hum Hypertens; 1995 Sep; 9(9):735-9. PubMed ID: 8551487
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
[TBL] [Abstract][Full Text] [Related]
36. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Altura BM; Altura BT
Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic and antihypertensive treatment responses with calcium antagonists.
Bolli P; Kiowski W; Erne P; Hulthén LU; Bühler FR
J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S126-30. PubMed ID: 2409361
[TBL] [Abstract][Full Text] [Related]
38. Influence of calcium entry blockade on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of hypertensive patients.
Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
Eur J Clin Pharmacol; 1987; 32(2):115-20. PubMed ID: 3034623
[TBL] [Abstract][Full Text] [Related]
39. Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
Touyz RM; Schiffrin EL
J Hypertens; 1994 Nov; 12(11):1255-63. PubMed ID: 7868873
[TBL] [Abstract][Full Text] [Related]
40. Drug interactions with nitrendipine.
Kirch W; Hutt HJ; Heidemann H; Rämsch K; Janisch HD; Ohnhaus EE
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S982-5. PubMed ID: 6085389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
